1.
|
Phase: Phase IV Type: Supportive care Status: Closed Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: CRUK-ON/2003/1772, EU-20640, EUDRACT-2004-004235-66, NAPP-CRUK-ON/2003/1772, NCT00378937
|
|
2.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Completed Age: 21 to 45 Sponsor: NCI, Other Protocol IDs: 2040.00, IR-6130, CDR0000551927, FHCRC-2040.00, FHCRC-2040.00p, NCT00499460
|
|
3.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 to 70 Sponsor: Pharmaceutical / Industry Protocol IDs: CR017437, 42801PAI3009, NCT01205126
|
|
4.
|
Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: OXN2001, 2007-001313-42, NCT00513656
|
|
5.
|
Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A4091003, NCT00545129
|
|
6.
|
Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: NEUROPAIN01, EudraCT Number 2007-005222-69, NCT00637975
|
|
7.
|
Phase: No phase specified Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MDA-2007-0791, 2007-0791, MDA-05-08-04, 8208, NCT00726830
|